MAIA Biotechnology MAIA
NYSE MAIA
$1.13 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

MAIA Biotechnology (MAIA) Selling, General & Administrative (2021 - 2026)

Updated

MAIA Biotechnology (MAIA) recorded Selling, General & Administrative of $2.68 million in Q2 2026, up 30.3% from $2.06 million a year earlier but down 21.8% from the prior quarter.

Analysis

MAIA Biotechnology (MAIA) Selling, General & Administrative (2021 - 2026) Analysis & Trends

On a TTM basis, MAIA Biotechnology's Selling, General & Administrative came in at $11.54 million as of Jun 30, 2026, up 47.2% year-over-year; for FY2025, it was $9.72 million, up 39.9% from FY2024.

  • Annual Selling, General & Administrative has a four-year compound annual growth rate of 22.7% (FY2021 to FY2025).
  • Across earlier years, Selling, General & Administrative came in at $6.95 million in FY2024 (-23.4%), $9.07 million in FY2023 (+47.6%), $6.14 million in FY2022 (+43.2%) and $4.29 million in FY2021.
  • Quarterly Selling, General & Administrative has ranged from $1.15 million in Q3 2021 to $3.42 million in Q1 2026 over the past five years.
  • On a year-over-year basis, Selling, General & Administrative has increased for six consecutive quarters, with growth averaging 24.4% over the last eight quarters.
  • Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 97.4% in Q3 2025, against a decline of 35.4% in Q3 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $3.42 million (Q1 2026), $2.44 million (Q4 2025) and $3 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn 6.29 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn 3.63 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn 3.24 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn 5.65 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn 1.92 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn 3.41 Bn
10 MAIA Biotechnology 68.39 Mn -13.17 Mn - 2.68 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.68 Mn
Mar 31, 2026 3.42 Mn
Dec 31, 2025 2.44 Mn
Sep 30, 2025 3.00 Mn
Jun 30, 2025 2.06 Mn
Mar 31, 2025 2.23 Mn
Dec 31, 2024 2.04 Mn
Sep 30, 2024 1.52 Mn
Jun 30, 2024 1.76 Mn
Mar 31, 2024 1.63 Mn
Dec 31, 2023 2.66 Mn
Sep 30, 2023 2.36 Mn
Jun 30, 2023 2.07 Mn
Mar 31, 2023 1.99 Mn
Dec 31, 2022 1.80 Mn
Sep 30, 2022 1.65 Mn
Jun 30, 2022 1.32 Mn
Mar 31, 2022 1.37 Mn
Dec 31, 2021 1.49 Mn
Sep 30, 2021 1.15 Mn
API Access

MAIA Biotechnology Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=MAIA&period=max&api_key=YOUR_API_KEY